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Purpose: The female menstrual cycle (MC) is characterized by hormonal fluctuations
throughout its different phases. However, research regarding its effect on athletic
performance in high level athletes is sparse. The aim of this study was to (i) investigate
the female MCs effect on strength and power performance in highly trained female team
athletes throughout the MC and (ii) examine whether eumenorrheic participants with
natural hormonal fluctuations displayed enhanced performance in the follicular phase
(FP) versus the luteal phase (LP), compared to controls using hormonal contraceptives.
Materials and Methods: A total of 29 athletes (Age 21.2 ± 3.3 years; weight
65.6 ± 8.7 kg; height 170.2 ± 8.0 cm; and fat free mass 52.7 ± 7.1) completed
the study after a 6-week testing period (8 eumenorrheic participants and 21 hormonal
contraceptive controls). Participants were recruited from the team sports soccer,
handball and volleyball. Testing protocol consisted of maximal voluntary isometric grip
strength, 20-m sprint, countermovement jump and pneumatic leg-press. Based on self-
reported use of hormonal contraceptives, participants were divided into non-hormonal
contraceptive group and hormonal contraceptive group, the latter working as a control
group. Differences in performance between the FP and LP were investigated. MC
phase was confirmed by serum hormonal levels through venous blood samples in the
non-hormonal contraceptive group.
Results: There were no statistically significant changes for the two different phases of
the MC, in terms of physical performance for the whole group. Further, there was no
significant difference between groups during the MC for any of the outcome variables,
maximal voluntary isometric grip strength F (3.29) = 0.362; 20-m sprint F (3.24) = 0.710;
countermovement jump F (3.26) = 2.361; and leg-press F (3.26) = 1.746.
Conclusion: In high level female team athletes, no difference in performance was
observed based on hormonal contraceptive status. This suggests that the MC does not
alter acute strength and power performance on a group level in high level team athletes.
Keywords: menstrual cycle, female athletes, strength, power, hormones
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INTRODUCTION
Modern intermittent team sports require a wide range of
physiological attributes in order to meet the demands
of the given sport. Strength and power are important
characteristics in intermittent team sports, hence, compelling
attributes to research in relation to physical performance
(Drust et al., 2007; Lidor and Ziv, 2010; Póvoas et al.,
2014). Although gender equality has been more in focus
in recent years, related to exposure, conditions and
professionalism in sport, females are underrepresented in
the scientific literature. Findings from studies investigating
male physiology and performance does not necessarily
translate to females, as the female menstrual cycle (MC)
cause monthly changes in serum hormone levels (Reilly, 2000)
that may affect strength, power, and endurance (Hansen, 2018;
Thompson et al., 2020).
The role of the sex hormones (estradiol and progesterone)
in addition to the pituitary hormones regulating the gonadal
axis [i.e., lutenizing hormone (LH)- and follicle stimulating
hormone (FSH)], in developing strength and power, is not
fully understood. Studies suggest that estradiol, one of the
primary sex hormone during the reproductive MC, induce
anabolic, and muscle building processes in females (Lowe
et al., 2010; Hansen et al., 2012). Furthermore, hormone
replacement therapy using exogenous estrogen seem to attenuate
loss of muscle strength in peri and post-menopausal women
(Carter et al., 2001; Minahan et al., 2015). The impact of
estradiol on muscle strength is not necessarily accomplished
by increased muscle size through hypertrophy, but rather
by affecting the intrinsic quality of skeletal muscle, enabling
muscle fibers to generate greater force (Lowe et al., 2010).
However, the role of estradiol during acute hormonal changes,
as seen amid the MC is not fully understood (Chidi-Ogbolu
and Baar, 2019). A second hormone playing an important
role during the female MC is progesterone. A decline in
progesterone levels (and estradiol levels) signals shedding of
the endometrium resulting in menstrual bleeding. Related to
sports, progesterone has been associated with protein catabolism,
conceivably attenuating muscle strength (Oosthuyse and Bosch,
2010). Indeed, studies have demonstrated ameliorated strength
levels during both the follicular phase (FP) and luteal phase
(LP) (Phillips et al., 1996; Birch and Reilly, 2002). These
conflicting finding makes understanding of potential superior
performance allocated to a specific MC phase speculative.
Sung et al. (2014) demonstrated increased muscle strength
and muscle diameter through strength training periodized to
the FP, compared to LP (Sung et al., 2014). Wikström-Frisén
et al. (2017) confirmed this finding and reported increased
power and strength gains through FP periodized training
(Wikström-Frisén et al., 2017). Despite this, several studies
within this field of research are hampered with insufficient
methodology, by lacking biological documentation of the MC
phase, which is seen as the gold standard (Allen et al.,
2016; Janse et al., 2019; Thompson et al., 2020). Studies with
unsatisfactory biological methodology also report increased
muscular performance through changes in serum hormonal
levels during and shortly prior to menstrual bleeding (Sarwar
et al., 1996; Bambaeichi et al., 2004).
A recently published systematic review investigating the effect
of MC and oral contraceptives on acute responses and chronic
adaptations to resistance training, concluded that the effects of
both the MC and oral contraceptive use on acute responses
to resistance training remain unclear (Thompson et al., 2020).
To summarize some findings of this review: (i) One of the 17
studies found no significant differences in acute responses to a
resistance training session over the natural MC, while four studies
did find changes (Thompson et al., 2020). (ii) For the responses
to a resistance training program, three studies reported FP -
based training to be superior to LP -based training or regular
training, while one study reported no differences (Thompson
et al., 2020). Finally, (iii) when assessing the differences in
acute responses between the oral contraceptive and MC groups,
two studies reported oral contraceptives to have a positive
influence, whilst four studies reported that oral contraceptive
users had a delayed recovery, higher levels of markers of
muscle damage, or both (Thompson et al., 2020). Some of the
conclusions made by this review is that FP -based resistance
training programs appear to result in better responses than LP
based and regular training programs. Furthermore, this review
highlights the need for further experimental research in this area
(Thompson et al., 2020).
We argue that more research is needed to investigate whether
hormonal fluctuations during the MC may alter performance
and in such have implications for periodic training and
competition. Furthermore, no studies have investigated the
effect of female sex hormone fluctuations on performance in
high-level team athletes, a sub-group where small changes
may have major impact. The aim of the study was therefore
(i) to examine potential changes in performance in high
level female team athletes during different phases of the MC
and (ii) to examine whether eumenorrheic participants, with
natural hormonal fluctuations during the MC display enhanced
performance during the FP versus the LP (due to higher relative




Women from six high-level teams from the Hordaland County
of western Norway, Norway, were invited to participate in the
study. Team sports invited were soccer, handball and volleyball,
competing at the top two national levels. Twelve players were
currently representing their national team. Five teams accepted
the invitation; one team declined due to logistics. Inclusion
criteria were (i) ≥18 years of age, (ii) competing at a national
level in their respective team sport, and (iii) free of any injury
or disease prohibiting testing. All participants satisfying inclusion
criteria (n = 55) received a baseline questionnaire via email
before the start of the intervention period. Of these, nine
team-members dropped out before testing, leaving the final
participant number at 46.
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During the testing period, additional five participants were
lost to follow up due to time commitment, school, or injury.
Four participants were excluded post hoc as they did not self-
report onset of menstruation during the 6-week testing period.
Additionally, eight participants were excluded as they did not
provide at least two test weeks from both FP and LP. Thus, the
total number of participants completing the study was Figure 1
(Age 21.2 ± 3.3 years; weight 65.6 ± 8.7 kg; height 170.2 ± 8.0 cm;
and fat free mass 52.7 ± 7.1). Group specific descriptive data are
presented in the section “Results.”
This study was approved by the Regional Ethics Committee
Norway (REK2018/1529).
Study Design
A prospective cohort study with repeated measures over 6-
weeks was executed. Exposure was hormonal contraceptive
(HC) status. Hormonal contraceptive group (HCG) and non-
hormonal contraceptive group (NHCG) were defined post hoc
(the participants HC status was unknown during the 6-week
testing period). The MC phases (FP and LP) were confirmed
through serum hormonal levels in blood samples taken at every
visit during the 6-week testing period, in the NHCG, to ensure
correct group assignment and validity of self-reported menstrual
phase. This validation procedure (hormonal values in serum
samples) was not performed in the HCG, as confirmation of
MC phase through blood samples is not possible due to a
steady flow of contraceptive specific exogenous sex hormones
throughout the MC (Allen et al., 2016). Self-reported onset of
menstruation was used in this group for assignment of FP and
LP phases. Guidelines provided by Sims and Heather (2018)
were used to choose test weeks included in the statistical analysis
for the HCG (Sims and Heather, 2018). More specifically, we
strived to test participants in the HCG using monophasic oral
contraceptives in the active pill phase. Blood samples of subjects
in the HCG were, however, drawn, but for other analytical
purposes (parallel study). HC types were recorded at baseline in
the HCG (Supplementary Table 3). Weekly outcome measures
(see testing procedure) were compared between the HCG and
NHCG. For this, four out of six testing weeks were selected
for statistical analysis to represent the FP and LP phases (FP
week 1/2 and LP week 3/4). Six weeks of consecutive testing
was performed to secure a minimum of two measurements in
both FP and LP, thus minimizing exclusion based on failure
to fulfill this requirement (e.g., week 1-4 and week 5-2 etc.).
This variation of included test weeks reduced the chance of a
systematic learning effect.
Testing Procedures
At baseline, all participants completed the LEAF-Q
questionnaire: a screening tool for the identification of female
athletes at risk for the female athlete triad. The questionnaire
comprises questions of age, height, weight, and BMI, as well
as more comprehensive information (sleep, nutrition, and
metabolism) for purposes beyond the scope of this study
(Melin et al., 2014).
On the day of testing, participants were encouraged to
eat approximately the same type and amount of food and
liquid throughout the testing period. They were also instructed
to avoid any caffeine consumption 12 h preceding testing,
due to the possible ergogenic effects related to physical
performance (Goldstein et al., 2010; Grgic et al., 2019a).
When arriving at the facility for testing, participants were
asked to complete a self-administered questionnaire regarding
MC, nutrition, training, injuries/pain, and test-day form
(expectations on test influence). Weight and body composition
were measured using multi-frequency bioelectrical impedance
(IN-body 720, Biospace, Tokyo, Japan), along with venous blood
samples for determination of menstrual phase. Before physical
testing, participants performed a 15-min standardized warm
up (100 watts) using the Wattbike ergometer (Wattbike Ltd.,
FIGURE 1 | Flow chart displaying the drop-out rate and exclusion during the study. N, number of participants; HC, hormonal contraceptive user; NHC, non-hormonal
contraceptive user. HC status for drop out prior to the start of the study is not included, due to incomplete questionnaires from some of the participants.
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Nottingham, United Kingdom). The weekly testing protocol
consisted of maximal voluntary isometric grip strength (MVIGS),
20-m sprint, Counter movement jump (CMJ) and leg-press.
Testing was completed once a week, at approximately the
same time each weekday to control for circadian variations
(±2 days/±2 h on the testing day). To minimize potential
bias through a learning effect, participants were given two
experimental attempts for every test, before recording started.
Maximal Voluntary Isometric Grip
Strength (MVIGS)
Isometric grip strength of the dominant hand was measured
using a digital pinch/grip analyzer (MIE, Medical research
Ltd, Leeds, United Kingdom). Standard instructions before and
during the test: (i) to be seated with a slight forward bend of
the trunk, elbow resting on the thigh with 90◦ elbow flexion,
(ii) exert maximal force for 3–5 s, (iii) two attempts with a 30 s
break between. If deviation from the instructions the attempt was
disallowed. If the force production in their last attempt exceeded
the previous with >5%, a new attempt was performed. The best
recording was used for statistical analysis. MVIGS is shown to
be a repetitive measure, with ICC-scores classified as very good
(Vassilis, 2012).
20-M Sprint
Sprint performance was assessed over a 20-m track, made
from portable non-slipping surface (Hitashita international, ON,
Canada). Times were recorded at 5, 10, and 20-m using single
beam photocells (Brower timing systems, Utah, United States).
Photocells were fixed at 120 cm height, apart from the first pair,
which were fixed at 10 cm height to ensure similar photocell
interception. participants were instructed to a stationary start
with the dominant leg behind and a slight forward bend of
the trunk. Participants decided when to start their effort, with
recording being initiated by interception of the first photocell
beam. Each subject carried out two attempts, separated by 2 min
of rest. If the second attempt was > 5% faster than the previous,
a new attempt was performed. The best total 20-m sprint time
was used for statistical analysis. 20-m sprint is shown to be a
repetitive measurement, with ICC-scores classified as very good
(Shalfawi et al., 2012). This method is also reviewed as reliable
in a comprehensive review of sprint performance monitoring
(Haugen and Buchheit, 2016).
Countermovement Jump
Counter movement jump performance started from an upright
position and the participants were instructed to descend to
a self-chosen depth, followed by a maximal vertical jump
effort. Participants were instructed to use a hand on hips
position throughout the entire movement. Maximum jump
height (cm) was calculated using Kistler Measurement, Analysis
and Reporting Software (MARS, 2015, S2P, Ljubljana, Slovenia).
Participants performed at least two attempts or continued
until performance declined. The best attempt was selected for
statistical analysis. CMJ is shown to be a repetitive measure, with
ICC-scores classified as very good (Slinde et al., 2008).
Leg Press
Relative peak power (RPP) was estimated using a progressive
maximal pneumatic resistance seated leg press test on a Keiser
A420 (Keiser, Fresno, CA, United States). An estimated 1-
Repetition maximum (1 RM) was chosen based on participants
self-reported training history, bodyweight, sport and previous
internal testing. Participants completed a 10-repetition
incremental step test toward peak of 1 RM on last repetition. The
test protocol is well established and described in detail elsewhere
(Redden, 2019). RPP was estimated using all 10 repetitions, and
each participant was to use the same protocol at every test point.
RPP measured and estimated with pneumatic leg press is shown
to be a repetitive measure, with ICC-scores classified as good
(Redden et al., 2018).
Serum Hormone Analysis
To provide hormonal confirmation of MC phase, participants
provided non-fasted venous blood samples before testing at every
visit, in order to avoid effect of physical strain on hormonal
levels. Blood was collected using eclipse blood collection needles
(BD vacutainer, Franklin Lakes, NJ, United States) in EDTA-
vials by qualified biomedical laboratory scientists. After 30 min,
blood samples were centrifuged at 2000×g for 10 min (Thermo
Fisher Scientific SL1R centrifuge, Thermo Fisher Scientific,
Waltham, MA, United States). Serum was isolated and stored
at −80◦C until all samples were collected during the 6-week
testing period prior to hormonal analysis. Serum samples were
analyzed for progesterone, estradiol, FSH, LH, and Sex hormone-
binding globin (SHBG). Analysis of progesterone and estradiol
levels were performed using Liquid Chromatography-Mass
Spectrometry (LC-MS/MS) (progesterone by the LC-system by
Agilent (Santa Clara, CA, United States) and MS-system: SICX,
while estradiol by LC-MS/MS by Waters). FSH, LH and SHBG
was analyzed by chemical luminescence on the Immulite 2000
XPi (Siemens, Erlangen, Germany). All hormone analyses were
performed at the Hormone Laboratory, Department of medical
biochemistry and pharmacology, Haukeland University Hospital.
All analyses are accredited according to NS-EN ISO 15189:2012.
Reference values used by the laboratory are presented in
Supplementary Table 4.
We performed a dichotomous division for FP and LP,
respectively. A progesterone value < 0.5 nmol/L was considered
true FP whereas a value > 5.5 nmol/L was considered true LP. In
some instances, we identified progesterone levels between 0.5 and
5.5 nmol/L. For these cases we evaluated the preceding and the
following weeks progesterone values. If the week prior presented
a progesterone value of >5.5 nmol/L, both weeks were considered
to be LP. In other cases, a low but measurable progesterone
value appeared, followed by a spike in progesterone. These cases
were labelled mid-cycle and were not included in the statistical
analysis, since it is difficult to conclude whether the value is
actually late FP or early LP.
Statistical Analysis
Descriptive statistics were used to examine the distribution of
subject characteristics across exposure groups. We calculated
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interclass correlation coefficients (ICC, random model) as
measures of reliability, based upon the four weekly measurements
chosen for analysis of performance during the MC. The results
are presented as mean ± standard deviation (SD). One-way
repeated measures analysis of variance (ANOVA) were used
to analyze for between group differences, between the average
results of two FP measures and two LP measures. ANOVA
was also conducted separately for the HCG and NHCG to
investigate potential within group chances between the FP and
LP. Bonferroni correction was conducted post hoc to reduce
the chance of type one error with significant ANOVA’s. An
alpha level of P < 0.05 was set a priori. Participants with
incomplete hormonal or performance data were excluded from
the statistical analysis. Between groups comparison is based on
the interaction between hormonal status∗menstrual cycle (time).
Statistical analysis was performed using IBM SPSS 25 (IBM,
Armonk, NY, United States).
RESULTS
A total of 29 participants were included in the study, 21 and
8 individuals in the HCG and NHCG, respectively. Mean age,
height, weight, fat free mass, and monthly training volume are
presented in Table 1. There was no statistical difference between
the two groups for any of these measures.
Self-reported onset of menstruation was registered in the
NHCG (n = 8) and compared with hormonal analyses to
investigate the accuracy of self-reported onset of menstruation.
We found deviating results in the self-reported data in two
individual cases (ID: D16, H3). Range of analyses in the different
phases of MC are presented in Supplementary Table 1. Reference
values for FP and LP are presented in Supplementary Table 4.
Repeated measures reliability was assessed as satisfactory
to excellent, with the following ICC vales; 0.75 for
countermovement jump, 0.80 for leg press, 0.88 for MVIGS, and
0.91 for 20-m sprint performance.
There were no statistically significant changes for the two
different phases of the MC, in terms of physical performance
for the whole group. Further, the interaction effect between
contraceptive status and time (MC phase) were compared. There
were no statistically significant group differences between the
HCG and NHCG for any outcome measures throughout the
TABLE 1 | Descriptive data showing mean values ± standard deviation of subject
characteristics in the hormonal contraceptive group and non-hormonal
contraceptive group.
Total HCG NHCG
N 29 21 8
Age 21.2 ± 3.3 20.48 ± 2.5 22.5 ± 4.2
Weight (kg) 65.6 ± 8.7 66.9 ± 8.3 63.1 ± 9.3
Height (cm) 170.2 ± 8.0 170 ± 7.6 168.8 ± 8.9
Fat free mass (FFM) 52.7 ± 7.1 53.4 ± 6.7 52.3 ± 7.9
Training volume (monthly hours) 52.8 ± 14.2 52.7 ± 14.9 52.9 ± 13.7
N, number of participants.
4 weeks chosen for analysis, although both groups showed
variation in performance (Figure 2 and Supplementary Table 2).
Additionally, no significant changes were observed when
investigating the MC cycle in both groups separately.
Despite non-significant findings, In terms of maximal
isometric grip strength both groups demonstrated weekly
variations in MVIGS, displaying the highest isometric grip
strength values for both groups in the LP with a mean of
31.3 ± 5.6 kg in the HCG and 28.7 ± 3.6 in the NHCG,
respectively (Figure 2 and Supplementary Table 2). Further,
both groups showed consistent measures for sprint performance
throughout the 4 weeks of the MC, with results ranging
from 3.194 ± 0.132 s to 3.209 ± 0.123 s in the HCG and
3.165 ± 0.121 s to 3.191 ± 0.116 s in the NHCG, respectively
(Figure 2 and Supplementary Table 2). With respect to counter
movement jump the CMJ displayed a greater between group
difference compared to the other tests, with means ranging from
32.9 ± 6.3 cm to 30.7 ± 4.3 cm in the HCG and 33.5 ± 4.7 cm
to 30.7 ± 2.7 cm in the NHCG, respectively (Figure 2 and
Supplementary Table 2). Finally, the NHCG displayed greater
variation between weeks in leg press compared to the HCG; means
ranging from 24.4 ± 2.9 W/kg to 23.3 ± 2.0 W/kg in the NHCG
compared to 23.6 ± 2.6 W/kg to 23.2 ± 2.8 W/kg in the HCG
(Figure 2 and Supplementary Table 2).
DISCUSSION
The aim of this study was to examine potential changes in
performance due to hormonal changes during the MC. This was
done by comparing test results from FP and LP between a NHCG
and HCG, the latter serving as controls over a 6-week period.
When comparing eumenorrheic participants with controls using
HC, we found no statistically significant differences for the MC
overall. Further, no statistically significant differences were found
for the FP when comparing the two groups. These findings
suggest that HC status does not alter strength and power
performance on a group level in high-level female team athletes,
when tested in a controlled environment throughout one MC.
Our findings are in line with several studies reporting no
difference in strength or power performance throughout the
different phases of the MC (Lebrun et al., 1995; Jonge et al.,
2001; Fridén et al., 2003; Bushman et al., 2006; Abt et al., 2007;
Julian et al., 2017; Romero-Moraleda et al., 2019). However,
there are studies reporting altering effects on strength and power
performance following periodized training regiments, adjusting
for hormonal fluctuations in the different MC phases (Thompson
et al., 2020). For instance, Sung et al. (2014) reported increased
muscle strength in participants following a FP periodized training
regimen, compared to a LP periodized training regiment, over a
total of three MC’s (Sung et al., 2014). Possibly, this procedure,
in contrast to acute performance as investigated in our study,
could better utilize the proposed mechanisms behind estradiol’s
ameliorating effects in muscle strength (Lowe et al., 2010). Our
study was cross-sectional, and we did not follow any specific
strength intervention and only provided data for one MC. This
might explain why the NHCG did not display any significant
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FIGURE 2 | Mean values through the menstrual cycle with 95% confidence intervals for (A) maximal voluntary grip strength, (B) 20-m sprint, (C) leg press, and (D)
countermovement jump. Week 1–4 (week 1/2 FP; week 3/4 LP) are based on serum hormonal levels.
alterations in their performance relative to the HCG. Further,
Phillips et al. (1996) reported up to 10% increase in maximal
voluntary force of the adductor pollicis during the FP of the
MC (Phillips et al., 1996). These findings contradict our result,
although we used MVIGS with a handheld dynamometer, which
is comparable with maximal voluntary force of the adductor
pollicis. Although not significant, in the current study, MVIGS
demonstrated small weekly variations in performance for both
groups with the greatest variations between FP and LP for both
groups. As the weeks are based on self-reported menstruation and
confirmation with hormonal analyses, representing the biological
week of the MC and not chronological test week, a systematic
learning effect can be ruled out. The fact that both groups showed
similar variations in their results, suggests that the MC was not
the impacting factor in the NHCG.
Counter movement jump displayed slight weekly non-
significant variations in the NHCG throughout the MC. In
contrast, the HCG showed a substantial deviation with a mean
difference of 2.2 cm between week two and four, which is a
6.9% difference. This manifested itself with a FP peak before
declining in the LP and can be viewed as a meaningful difference,
considering the marginal differences in high level sport. If
estradiol indeed does ameliorate muscle strength and power,
this increase in performance would be plausible. However, with
HC agents providing a steady supply of exogenous hormones
throughout the MC, minimizing the hormonal fluctuations, this
weekly difference in the HCG was unexpected. As highlighted
by Myllyaho et al. (2018), different HC agents may exert varying
effects of performance (Myllyaho et al., 2018). Hence, this might
be a line of investigation interesting to follow in future studies, by
separating groups of different HC agents.
Relative peak power showed weekly variations, with the
NHCG displaying the greatest change between week one and two,
with a mean difference of 1.1 w/kg. For this outcome, the greatest
value manifested itself in the FP. This is in line with previous
research, demonstrating superior performance in the FP (Phillips
et al., 1996; Greeves et al., 1997). However, the outcome measures
of both these studies are quite reductionistic. Further, MC phase
was not necessarily verified through serum blood samples, giving
these results low validity (Allen et al., 2016).
A total of 20-m sprint displayed the least variation in
both groups. Since repeated measures ICC was high for sprint
measures, these results cannot be explained as uncertainty of
the measurement method to detect small changes, but rather
demonstrates stable performance across the testing period.
Further, it is possible 20-m was too short of a distance to measure
any meaningful difference, as results were very marginal.
Although no significant findings were detected between
groups, several variables showed substantial weekly variations in
performance in both the HCG and NHCG. As small changes
in performance may impact results in high level sport, our
findings indicate that the time of testing could yield different
results for high level female athletes in general. However,
these variations cannot directly be contributed to hormonal
fluctuations occurring during the MC. One plausible explanation
for the weekly variations observed in this study is individual
physiological load. Indeed, Andersson et al. (2008) demonstrated
that full match recovery in female soccer players can last up
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to 72 h. The recovery time from handball is also proven to be
substantial (Ronglan et al., 2006; Andersson et al., 2008).
Our study contradicts the suggestion that estradiol acutely
ameliorates muscle strength and power, supporting the findings
of Jonge et al. (2001), showing no correlation between estradiol
serum hormonal levels and muscle strength, fatiguability, and
contractile properties (Jonge et al., 2001). Serum estradiol levels
varied in the range from 35 pmol/L to 1122 pmol/L. As
highlighted by Jonge et al. (2001), the large variations seen in
serum estradiol levels is partly caused by secretory pulses of
these hormones. In addition, the MC is highly individual in their
length, thus, the participants may have been in different stages of
their respective cycles. This is in line with Greeves et al. (1997)
who demonstrated that supraphysiological doses of estradiol
did not significantly increase muscle strength, questioning the
findings of Phillips et al. (1996), and Sarwar et al. (1996),
suggesting that acute changes in estradiol ameliorates muscular
strength (Phillips et al., 1996; Sarwar et al., 1996).
Indeed, several studies have shown estradiol hormone
replacement therapy to be beneficial in decreasing attenuation
of muscle strength in peri and post-menopausal women, as
summarized by Chidi-Ogbolu & Baar (Chidi-Ogbolu and Baar,
2019). Lowe et al. (2010) hypothesize that estradiol alters myosin
function during muscle contractions through estradiol receptors
in a typical steroid manner (Lowe et al., 2010). As described
by the aforementioned authors, skeletal muscle is an estradiol
receptive tissue, working through the estradiol receptor. This may
help explain why studies adopting periodized training protocols,
utilizing elevated circulating estradiol levels over time have
demonstrated increased muscle strength, as opposed to more
modest results displayed when measuring acute performance.
Exploiting a preferable milieu may promote strength gains over
time, as adaptations in skeletal muscle may need time to manifest
themselves, even if estradiol alone also improves the intrinsic
quality of contractile fibers. Individual estrogen receptor content
may therefore be partly indicative of muscle strength gains
and performance.
As highlighted by Sims and Heather (2018), HC users are
proposed as suitable controls when measuring the effects of
the MC (Sims and Heather, 2018). However, several types
of contraceptive agents, with different active ingredients and
exogenous hormones were administered in the HCG. Thus, the
impact on performance may vary, depending on the type of
contraceptive agent being used. To our knowledge, there is no
study investigating the effect on different type of HC’s related
to athletic performance in high level athletes. Considering the
current lack of knowledge related to different HC agents and
performance, we would like to re-emphasize the need for future
research regarding this manner.
Methodological Considerations and
Limitations
This study highlights the possibility of conducting prospective
research on female athletes, which is often considered
problematic due to training and competition schedule,
paired with female physiology. A further strength is the
prospective study design, were we measured 6 weeks and
chose 4 weeks, representing the MC based on self-reported
onset of menstruation and hormonal confirmation. However,
measurements over several MC’s would have provided increased
validity, due to individual variation in MC length and onset.
Comparing self-reported onset of menstruation to hormonal
analysis, revealed deviating results in four participants.
Although some of these variations may be contributed to
survey misunderstandings, the results indicate that some
caution should be made when interpreting studies exclusively
applying this method for MC phase determination. Although
no statistical difference was observed between the two groups,
some interindividual variability was present in both groups.
With a relatively small sample size, it is possible that the results
would approach being statistically significant with a larger
population. Further, a potential limitation is small variations
in test procedures. Testing was originally scheduled for the
same day (± 2 days) and time (±2 h) throughout the study
period to account for circadian variations. However, due to
national team obligations and training/competition schedules
being fluctuant in pre-season, some participants were tested
outside these frames at one or several time points. This could
have impacted the results, as circadian rhythm has been shown
to affect performance in strength and power endeavors (Grgic
et al., 2019b). Grgic et al. (2019b) reported that expression of
strength is greater in the evening, versus the morning. On the
other hand, the circadian effects on test results also depend on
athletes normal training schedule (Grgic et al., 2019b). Thus, the
impact of variation in test procedures on the final results is not
fully known. Indeed, the relatively low sample size limits external
validity. On the other hand, the participants were selected based
on stringent criteria’s before entering the study, increasing the
likelihood of being representative for high level female team
athletes within the relevant sports. As described earlier, HCG
testing weeks was selected based on self-reported menstruation.
Although we strived to follow guidelines presented by Sims and
Heather (2018), this method of validation should be interpreted
with caution (Sims and Heather, 2018). Finally, we chose to limit
testing to FP and LP exclusively. Ideally, hormonal validation
of MC phase should have included ovulation. Further, FP and
LP could have been divided to include early and late FP and LP.
Due to time and financial reasons, this was not done. Hence, this
limits our result, due to variations in serum hormonal levels in
different parts of FP and LP, respectively.
CONCLUSION
In this study, there was no statistically significant changes
for the two different phases of the MC, in terms of
physical performance in high level female team athletes.
Further, testing of strength and power performance
parameters were not significantly affected by HC status
when comparing an HCG and NHCG during the MC. These
findings suggest that MC phase should not be of major
consideration for athletic testing or competition, emphasizing
strength and power performance. However, interindividual
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variability in results and hormonal levels, together with a
small sample size makes firm guidelines arduous. Based on
our study and the current literature, possible alterations to
strength and power performance elicited by the MC are
more likely to occur during long term MC phase dependent
training interventions, rather than acute testing of performance.
Our findings should be interpreted with caution, due to the
limitations of the study.
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